Citigroup’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,900
| Closed | -$1.66M | – | 5893 |
|
|
2024
Q3 | $1.66M | Buy |
+14,900
| New | +$1.63M | ﹤0.01% | 2823 |
|
|
2021
Q1 | – | Sell |
-9,800
| Closed | -$1.62M | – | 6839 |
|
|
2020
Q4 | $1.62M | Sell |
9,800
-5,500
| -36% | -$819K | ﹤0.01% | 3063 |
|
|
2020
Q3 | $2.18M | Sell |
15,300
-5,200
| -25% | -$645K | ﹤0.01% | 2575 |
|
|
2020
Q2 | $2.26M | Buy |
20,500
+5,800
| +39% | +$641K | ﹤0.01% | 2680 |
|
|
2020
Q1 | $1.47M | Sell |
14,700
-5,400
| -27% | -$698K | ﹤0.01% | 2794 |
|
|
2019
Q4 | $3M | Sell |
20,100
-15,400
| -43% | -$2.1M | ﹤0.01% | 2537 |
|
|
2019
Q3 | $4.55M | Sell |
35,500
-23,300
| -40% | -$3.12M | ﹤0.01% | 2038 |
|
|
2019
Q2 | $8.38M | Buy |
58,800
+46,800
| +390% | +$6.29M | 0.01% | 1528 |
|
|
2019
Q1 | $1.72M | Sell |
12,000
-46,600
| -80% | -$6.08M | ﹤0.01% | 2822 |
|
|
2018
Q4 | $7.26M | Buy |
58,600
+46,600
| +388% | +$6.91M | 0.01% | 1509 |
|
|
2018
Q3 | $2.02M | Sell |
12,000
-19,000
| -61% | -$3.27M | ﹤0.01% | 2739 |
|
|
2018
Q2 | $5.34M | Buy |
31,000
+24,200
| +356% | +$3.96M | ﹤0.01% | 1777 |
|
|
2018
Q1 | $1.03M | Buy |
6,800
+3,000
| +79% | +$440K | ﹤0.01% | 3220 |
|
|
2017
Q4 | $512K | Sell |
3,800
-7,200
| -65% | -$999K | ﹤0.01% | 4069 |
|
|
2017
Q3 | $1.61M | Sell |
11,000
-28,500
| -72% | -$4.31M | ﹤0.01% | 2895 |
|
|
2017
Q2 | $6.14M | Buy |
39,500
+19,600
| +98% | +$3M | 0.01% | 1538 |
|
|
2017
Q1 | $2.89M | Buy |
19,900
+6,800
| +52% | +$886K | ﹤0.01% | 2129 |
|
|
2016
Q4 | $1.43M | Sell |
13,100
-5,500
| -30% | -$613K | ﹤0.01% | 3313 |
|
|
2016
Q3 | $2.26M | Sell |
18,600
-600
| -3% | -$80.9K | ﹤0.01% | 2405 |
|
|
2016
Q2 | $2.71M | Buy |
19,200
+2,500
| +15% | +$369K | ﹤0.01% | 2099 |
|
|
2016
Q1 | $2.18M | Buy |
16,700
+7,500
| +82% | +$934K | ﹤0.01% | 2393 |
|
|
2015
Q4 | $1.29M | Sell |
9,200
-800
| -8% | -$111K | ﹤0.01% | 2855 |
|
|
2015
Q3 | $1.33M | Buy |
10,000
+4,700
| +89% | +$809K | ﹤0.01% | 2810 |
|
|
2015
Q2 | $933K | Buy |
5,300
+4,600
| +657% | +$826K | ﹤0.01% | 3202 |
|
|
2015
Q1 | $121K | Buy |
+700
| New | +$120K | ﹤0.01% | 4877 |
|
|
2014
Q4 | – | Sell |
-144,300
| Closed | -$23.2M | – | 7207 |
|
|
2014
Q3 | $23.2M | Buy |
+144,300
| New | +$22.2M | 0.02% | 719 |
|
|
2014
Q2 | – | Sell |
-15,000
| Closed | -$2.08M | – | 7223 |
|
|
2014
Q1 | $2.08M | Buy |
+15,000
| New | +$2.26M | ﹤0.01% | 2329 |
|
|
2013
Q3 | – | Sell |
-20,000
| Closed | -$1.38M | – | 6889 |
|
|
2013
Q2 | $1.38M | Buy |
+20,000
| New | +$1.22M | ﹤0.01% | 2642 |
|
Other funds holding JAZZ
VPM
VCM
EC
Citigroup's JAZZ Position: Q1 2026 in Review
Citigroup increased its Jazz Pharmaceuticals (JAZZ) stake by 137% in Q1 2026, buying an estimated $12.7M and bringing the position to 125,348 shares worth $23.7M. The position accounts for 0.01% of the portfolio, ranked #975.
Citigroup first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.7M in Q3 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Citigroup held 125,348 shares of Jazz Pharmaceuticals worth $23.7M as of Q1 2026.
- Citigroup bought 72,543 Jazz Pharmaceuticals shares in Q1 2026, an estimated $12.7M.
- Jazz Pharmaceuticals made up 0.01% of Citigroup's portfolio in Q1 2026, its #975 holding.
- Citigroup first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Jazz Pharmaceuticals position peaked at $24.7M in Q3 2025.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.